Lv23
190 积分 2023-12-06 加入
Exploring the contribution of ARMS2 and HTRA1 genetic risk factors in age-related macular degeneration
5小时前
待确认
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: A safe and efficacious 12-month treatment for melasma
10小时前
求助中
Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial
1天前
已完结
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
14天前
已完结
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
14天前
已完结
Advancements in age-related macular degeneration treatment: From traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnology
16天前
已完结
Age-Related Macular Degeneration
16天前
已完结
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
21天前
已完结
Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibody
28天前
已完结
皖公网安备34019202002308
